Report copyright - TAKEDA ONCOLOGY: INNOVATIVE CELL THERAPIES & NEW … · 14/11/2019 · CAR‐NK (allocord blood) • Non‐autologous NK cell therapy TAK‐007 (CD19 CAR‐NK) BCMA CAR‐NK = first‐in‐class
Please pass captcha verification before submit form
Please pass captcha verification before submit form